首页> 外文期刊>Expert opinion on therapeutic targets >S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.
【24h】

S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.

机译:O6-甲基鸟嘌呤-DNA-甲基转移酶(MGMT)的S-烷硫基化使癌细胞对抗癌治疗敏感。

获取原文
获取原文并翻译 | 示例
           

摘要

O6-methylguanine DNA methyltransferase/O6-alkylguanine DNA alkyltransferase (MGMT/AGT) removes alkyl adducts from the O6-position of guanine in DNA. Expression of MGMT in human cancers has been associated with resistance to therapies using alkylating agents. MGMT promoter methylation regulates its expression and response to alkylating agents. A combination of O6-benzylguanine-based inhibitors of MGMT with alkylating agents improved the efficacy. However, this is associated with enhanced cytotoxicity and the induction of GC to AT transition mutations presumably also in progenitor/stem cells. A few recent studies have described analogs of O6-benzylguanine targeting defined pathways of cancer cells that can be used to improve the selectivity of O6-benzylguanine-based inhibitors for cancer cells. Therefore, MGMT inhibitor targeting represents a reliable strategy for improving cancer therapy with alkylating agents.
机译:O6-甲基鸟嘌呤DNA甲基转移酶/ O6-烷基鸟嘌呤DNA烷基转移酶(MGMT / AGT)从DNA中鸟嘌呤的O6-位置去除烷基加合物。 MGMT在人类癌症中的表达与使用烷基化剂的治疗耐药性有关。 MGMT启动子甲基化调节其表达和对烷基化剂的反应。基于O6-苄基鸟嘌呤的MGMT抑制剂与烷基化剂的组合可提高疗效。但是,这可能与增强的细胞毒性以及祖细胞/干细胞中GC向AT过渡突变的诱导有关。最近的一些研究描述了靶向癌细胞的确定途径的O6-苄基鸟嘌呤类似物,其可用于改善基于O6-苄基鸟嘌呤的抑制剂对癌细胞的选择性。因此,靶向MGMT抑制剂代表了一种使用烷基化剂改善癌症治疗的可靠策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号